The 17th China Shenzhen Innovation and Entrepreneurship Competition has successfully concluded in 2025. During the sector finals, Shenzhen Keye Life Technology Co., Ltd. garnered high praise from the judges and stood out among numerous outstanding projects with its groundbreaking drug development project targeting the world's first-in-class target, RNA helicase DHX33, earning the second prize in the sector finals. This award recognizes Keye Life's commitment to the path of hardcore technology with true innovation.

Traditional anticancer drug development often involves iterating on already mature targets, whereas Keye Life has chosen a more challenging path that holds the potential for breakthrough efficacy. Its award-winning project elaborates a novel targeted therapy technology designed to address the current treatment challenges of refractory tumors. Specifically, it focuses on developing small molecule inhibitors with high selectivity and potent activity against the RNA helicase DHX33 protein, which plays a critical role in various malignant tumors.

The Shenzhen Innovation and Entrepreneurship Competition is an official, top-tier event led by the Shenzhen Municipal People's Government and organized by the Shenzhen Municipal Science, Technology and Innovation Commission. Its value and influence far exceed those of conventional regional contests. Serving as a direct pathway to the China Innovation and Entrepreneurship Competition, it represents Shenzhen's highest standard for evaluating scientific and technological innovation projects. The judging panel, composed of partners from leading investment institutions, renowned entrepreneurs, and technical experts, ensures the professionalism and credibility of the evaluation process. Attracting top-tier technology teams from both China and abroad to compete on the same stage, the competition's awards themselves serve as an authoritative endorsement of a project's technological barriers, business model, and team strength.

This award not only marks a solid step forward for Keye Life in the field of innovative drug research and development but also highlights Shenzhen's remarkable achievements in fostering strategic emerging industries and encouraging hardcore technological innovation, contributing significantly to the "Healthy China" strategy.